XML 38 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Business - Narrative (Details)
3 Months Ended
Mar. 31, 2023
USD ($)
patent
Mar. 31, 2022
Dec. 31, 2022
USD ($)
May 28, 2021
USD ($)
Debt Instrument [Line Items]        
Number of patents issued | patent 19      
Number of pending patents | patent 8      
Cash and cash equivalents $ 2,000,000      
Net working capital 732,000      
Accumulated deficit $ 160,497,663   $ 157,057,558  
Sales Agreement        
Debt Instrument [Line Items]        
Sale of stock, consideration received on transaction, authorized amount       $ 14,611,900
Period for which advance notice is due to terminate agreement       10 days
Commission fee, percent       3.00%
Net Revenue | Customer Concentration Risk | Customer One, Two, Three and Four        
Debt Instrument [Line Items]        
Percentage of concentration risk   67.00%    
Net Revenue | Customer Concentration Risk | Customer One, Two, and Three        
Debt Instrument [Line Items]        
Percentage of concentration risk 66.30%      
Net Revenue | Customer Concentration Risk | Customer One        
Debt Instrument [Line Items]        
Percentage of concentration risk 26.40% 22.00%    
Net Revenue | Customer Concentration Risk | Customer Two        
Debt Instrument [Line Items]        
Percentage of concentration risk 25.30% 18.20%    
Net Revenue | Customer Concentration Risk | Customer Three        
Debt Instrument [Line Items]        
Percentage of concentration risk 14.60% 14.50%    
Net Revenue | Customer Concentration Risk | Customer Four        
Debt Instrument [Line Items]        
Percentage of concentration risk   12.30%    
Accounts Receivable | Customer Concentration Risk | Customer One, Two, Three and Four        
Debt Instrument [Line Items]        
Percentage of concentration risk   64.10%    
Accounts Receivable | Customer Concentration Risk | Customer One, Two, and Three        
Debt Instrument [Line Items]        
Percentage of concentration risk 24.00%